QQ客服 官方微博 反馈留言

	普米克令舒联合氨溴索雾化治疗在晚期新生儿肺炎患儿中的应用价值探讨; Discussion on application value of pulmicort respulas combined with ambroxol and inhalation method in late neonatal pneumonia
	颜才进 ; 张远晖
	2014-05-10
关键词	晚期新生儿肺炎 普米克令舒 雾化 氨溴索 应用价值 Late neonatal pneumonia Pulmicort respulas Inhalation Ambroxol Application value
英文摘要	目的探讨普米克令舒联合氨溴索雾化在治疗晚期新生儿肺炎患儿中的应用价值。方法将晚期新生儿肺炎患儿随机分为实验组和对照组,对照组给予积极抗感染和对症治疗,实验组除外对照组处理还给予普米克令舒联合氨溴索雾化吸入治疗,比较两组患儿疗效、症状体征改善情况。结果实验组疗效整体优于对照组,且在退热时间、体征变化时间和住院时间上早于对照组,差异有统计学意义(P<0.05)。结论普米克令舒联合氨溴索雾化治疗晚期新生儿肺炎效果显著,能明显提高患儿治愈率,改善患儿临床症状和体征并缩短病程。; Objective To discuss the application value of pulmicort respulas combined with ambroxol with the inhalation method in late neonatal pneumonia.Methods The late neonatal pneumonia children were randomly divided into experimental group and control group, control group was given positive anti-infection and symptomatic treatment, the experimental group was given not only above but also pulmicort respulas combined with ambroxol with the inhalation method.Compared two groups of children with curative effect, the signs and symptoms improvement.Results Experimental group curative effect is better than that of control group whole, and signs of change is earlier than the control group in antifebrile time and hospital stay time, the difference is statistically significant(P<0.05).Conclusion The late neonatal pneumonia children in therapy of pulmicortrespulas combined with ambroxol with the inhalation method is remarkable, which can obviously increase the cur rate, improve the clinical signs and symptoms and shorten the course of the disease.Key words
语种	zh_CN
内容类型	期刊论文
源URL	[http://dspace.xmu.edu.cn/handle/2288/123491]
专题	药学院－已发表论文
推荐引用方式 GB/T 7714	颜才进,张远晖. 普米克令舒联合氨溴索雾化治疗在晚期新生儿肺炎患儿中的应用价值探讨, Discussion on application value of pulmicort respulas combined with ambroxol and inhalation method in late neonatal pneumonia[J],2014.
APA	颜才进,&张远晖.(2014).普米克令舒联合氨溴索雾化治疗在晚期新生儿肺炎患儿中的应用价值探讨..
MLA	颜才进,et al."普米克令舒联合氨溴索雾化治疗在晚期新生儿肺炎患儿中的应用价值探讨".(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。